About Eshwar Pharmaceuticals
Eshwar Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2008. It develops and manufactures active pharmaceutical ingredients and intermediates for the healthcare industry. It operates on a B2B model. Its Indian entity Eshwar Pharmaceuticals Private Limited reported revenue of ₹3.36 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Eshwar Pharmaceuticals develops and manufactures active pharmaceutical ingredients and intermediates for the healthcare industry, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Website eshwarpharma.com
- Legal Name Eshwar Pharmaceuticals Private Limited
- Date of Incorporation 14 May, 2008
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹3.36 Cr
FY 2018 · -35% YoY
- Net Loss-₹2.65 Cr
FY 2018 · -79% margin
- EBITDA-₹1.84 Cr
FY 2018 · -55% margin
Associated legal entities of Eshwar Pharmaceuticals
Eshwar Pharmaceuticals is associated with 2 registered companies on The Company Check; the primary company is Eshwar Pharmaceuticals Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2018) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eshwar Pharmaceuticals Private Limited CIN U24232TG2008PTC059164 | Converted To Llp | 14 May 2008 | Hyderabad, Telangana | ₹3.4 Cr | 1 | View details | |
| Eshwar Pharmaceuticals Llp CIN AAP-0278 | Strike Off | 23 Apr 2019 | Hyderabad, Telangana | ₹0.2 Cr | 2 | View details |
Board of directors of Eshwar Pharmaceuticals Private Limited (Eshwar Pharmaceuticals)
Eshwar Pharmaceuticals Private Limited is the primary company behind Eshwar Pharmaceuticals. The board of Eshwar Pharmaceuticals Llp currently have 2 directors; the longest-serving is Krishna Chaitanya Potluri, appointed in 2019. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Krishna Chaitanya Potluri DIN 02990767 | Designated Partner | 23 Apr 2019 | 7 yrs 6 mo | Eshwar Pharmaceuticals Llp |
| Hari Kishore Potluri DIN 00171579 | Designated Partner | 23 Apr 2019 | 7 yrs 6 mo | Eshwar Pharmaceuticals Llp |
Financials of Eshwar Pharmaceuticals
Figures of Eshwar Pharmaceuticals Private Limited, the primary company behind Eshwar Pharmaceuticals, for FY 2018. Revenue was ₹3.36 Cr (-35% year on year). Net loss was -₹2.65 Cr (-79% margin). EBITDA was -₹1.84 Cr (-55% margin). Revenue has grown at a compounded annual rate of -17% over three years.
- ₹3.36 CrRevenue · FY 2018 · -35% YoY
- -₹2.65 CrNet loss · -79% margin
- -₹1.84 CrEBITDA · -55% margin
- ₹1.56 CrPaid-up capital
- 1Employees (provident fund records)
- -17%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Eshwar Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Eshwar Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Eshwar Pharmaceuticals
Eshwar Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Eshwar Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eshwar Pharmaceuticals
Eshwar Pharmaceuticals was founded in 2008.
Eshwar Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Eshwar Pharmaceuticals, Eshwar Pharmaceuticals Private Limited, reported revenue of ₹3.36 Cr for FY 2018, down 35% year on year.
Eshwar Pharmaceuticals develops and manufactures active pharmaceutical ingredients and intermediates for the healthcare industry, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Eshwar Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Eshwar Pharmaceuticals is associated with 2 legal entities: Eshwar Pharmaceuticals Private Limited, Eshwar Pharmaceuticals Llp.
The legal entities of Eshwar Pharmaceuticals currently have 2 directors, including Krishna Chaitanya Potluri, Hari Kishore Potluri.